Reports published annually by the appropriations committees do not rank high in the hierarchy of legislative documents.
The question of what it would take to get an NCI designation is especially relevant at West Virginia University, one of a growing number of institutions that have embarked upon the path of seeking this distinction.
The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month.
The FDA Oncologic Drugs Advisory Committee voted unanimously 16-0 to recommend approval of CT-P10, a proposed monoclonal antibody biosimilar to Rituxan (rituximab) for the treatment of adult patients in three proposed indications.
Myriad Genetics Inc. and Pfizer Inc. announced a commercialization plan under an existing companion diagnostic agreement, in which Myriad is pursuing FDA approval for its BRACAnalysis CDx to be used as a companion diagnostic with Pfizer's investigational PARP inhibitor, talazoparib.
Foundation Medicine Inc. said that FoundationOne Liquid, a liquid biopsy test for solid tumors, is commercially available in the U.S.
Celyad announced an exclusive agreement with Horizon Discovery Group plc, for the use of its shRNA technology to generate Celyad's second non-gene- edited allogeneic platform.
A UPMC-developed test for diagnosis of thyroid nodules, ThyroSeq Genomic Classifier, has been approved for coverage by its Medicare Administrative Contractor, Novitas Solutions. This decision paves the way for the test to be accessible to more than 50 million Medicare patients nationwide.
Three medical societies today issued a new clinical guideline for physicians treating men with early-stage prostate cancer using external beam radiation therapy.
The Maryland Proton Treatment Center is offering deep-tissue external thermal therapy in combination with high-precision proton-beam radiotherapy as a potential way to boost survival chances for certain cancer patients. MPTC is the only center in the world to offer these two treatments at the same facility, an advantage to patients because these therapies are typically given within an hour of each other.
